Autologous CAR-T cells / UTC Therap - LARVOL DELTA

Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: Shanghai Pudong Hospital | N=20 ➔ 0 | Recruiting ➔ Withdrawn

CAR T-Cell Therapy • Enrollment change • Trial withdrawal • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Adult T-Cell Leukemia-Lymphoma • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Multiple Myeloma • Non-Hodgkin’s Lymphoma • Oncology • CD19

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies (clinicaltrials.gov) - P1 | N=10 | Recruiting | Sponsor: The Affiliated People's Hospital of Ningbo University

CAR T-Cell Therapy • New P1 trial • Hematological Disorders • Hematological Malignancies • Leukemia • Lymphoma • Multiple Myeloma • Oncology